These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19649923)

  • 1. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.
    Sibley CD; Parkins MD; Rabin HR; Surette MG
    Curr Opin Investig Drugs; 2009 Aug; 10(8):787-94. PubMed ID: 19649923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cystic fibrosis airway microbiome.
    Rabin HR; Surette MG
    Curr Opin Pulm Med; 2012 Nov; 18(6):622-7. PubMed ID: 22965275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on antibiotics for infection control in cystic fibrosis.
    Kirkby S; Novak K; McCoy K
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):967-80. PubMed ID: 19803706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic synergy testing should not be routine for patients with cystic fibrosis who are infected with multiresistant bacterial organisms.
    Aaron SD
    Paediatr Respir Rev; 2007 Sep; 8(3):256-61. PubMed ID: 17868924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic use in cystic fibrosis.
    Eisenberg JD
    Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations.
    Keays T; Ferris W; Vandemheen KL; Chan F; Yeung SW; Mah TF; Ramotar K; Saginur R; Aaron SD
    J Cyst Fibros; 2009 Mar; 8(2):122-7. PubMed ID: 19064337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
    Esmond G; Butler M; McCormack AM
    J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.
    Waters V; Ratjen F
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):807-19. PubMed ID: 17140357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis.
    Sherrard LJ; Tunney MM; Elborn JS
    Lancet; 2014 Aug; 384(9944):703-13. PubMed ID: 25152272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP; Brownlee KG; Denton M; Peckham DG
    Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolides in cystic fibrosis.
    McArdle JR; Talwalkar JS
    Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacterial infections of the lungs in mucoviscidosis patients].
    Hogardt M; Heesemann J
    MMW Fortschr Med; 2005 Jan; 147(4):38-40. PubMed ID: 15745340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary infections in children with cystic fibrosis.
    Stutman HR; Marks MI
    Semin Respir Infect; 1987 Sep; 2(3):166-76. PubMed ID: 3317617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The airway microbiome in cystic fibrosis and implications for treatment.
    Zemanick ET; Sagel SD; Harris JK
    Curr Opin Pediatr; 2011 Jun; 23(3):319-24. PubMed ID: 21494150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture.
    Sibley CD; Surette MG
    Can J Microbiol; 2011 Feb; 57(2):69-77. PubMed ID: 21326348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection.
    McCaughey G; Gilpin D; Elborn J; Tunney MM
    Expert Rev Respir Med; 2013 Aug; 7(4):385-96. PubMed ID: 23964628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment of CF lung disease: from bench to bedside.
    Bals R; Hubert D; Tümmler B
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S146-51. PubMed ID: 21658633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.